HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients. - Wikidata - wikimedia - TriplyDB

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

http://www.wikidata.org/entity/Q35027220

about

Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis The atherogenic index of plasma and the risk of mortality in incident dialysis patients: Results from a nationwide prospective cohort in Korea.Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.Dialysis Modalities and HDL Composition and Function Triglyceride to high-density lipoprotein cholesterol ratio predicts cardiovascular outcomes in prevalent dialysis patients.Apoprotein B/Apoprotein A-1 Ratio and Mortality among Prevalent Dialysis Patients.APOC3 induces endothelial dysfunction through TNF-α and JAM-1 HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.High-Density Lipoprotein in Chronic Kidney Diseases-The Devil Is in the Detail.Apolipoprotein B/apolipoprotein A1 ratio and mortality among incident peritoneal dialysis patients.

P2860

Q28083619-346F9C4F-5D6C-4236-9F3E-B5B0B242DF89 Q33704372-FBE13341-61E2-43D2-A9C1-619ABD3474CD Q33732285-945FFB95-77C6-4A70-A167-75F76AFFC81A Q35051225-7B3C9E7E-AD4A-4B31-B3C3-8E49B59CED93 Q36003077-CBA4D1CC-1BA2-4BB6-8A50-1F7130D35AE6 Q36151033-518151BF-BEC2-4043-9FB5-550E5D4FD9F9 Q36874560-113B935B-E5A3-486E-A551-58ADBA3B3C0F Q37251472-3A8D1A92-BDBA-4806-A5AE-3436A6B7CEED Q40587729-72FD8731-25ED-4A65-99A8-3A10F05D2D15 Q41507824-65342355-A607-464B-9819-8D94E29B1336 Q52374541-0C7727F4-9375-436D-BBAF-E3E3E81DE393 Q55002489-146CC066-9CF0-492C-AE2F-0A991D7BD930

P2860

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

http://www.wikidata.org/entity/Q35027220

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

@ast

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

@en

type

label

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

@ast

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

@en

prefLabel

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

@ast

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

@en

P1433

Q35027220-28812A0E-E33C-435E-9C9E-9D4A0BB3A6C0

P1476

Q35027220-ADED6513-72A3-409F-B109-33E31069A62D

P2093

Q35027220-068555EB-5544-44E3-B4A0-28D3F183C1D0

Q35027220-084C43CA-2D65-4818-A79A-5C21438ABEBC

Q35027220-1AA26EF3-E489-40DE-BD9C-667150541089

Q35027220-57D15051-6BAF-4BC2-BE56-5AC81364B660

Q35027220-692D43EE-AB43-43AC-999F-99AE98746A02

Q35027220-C6181BDF-4B5C-4214-ADCE-CBCAD675FDA6

Q35027220-F7B40A0A-12EF-4D0B-889B-C795FDE2F707

P2860

Q35027220-20F641C9-CFD8-44AC-A44C-352C99134305

Q35027220-2B5D9227-299B-40BD-8EC1-85DBA84565FC

Q35027220-349AA9F4-9B7C-4130-B283-993508027839

Q35027220-35D984A5-DE95-4651-B820-44CB2B889985

Q35027220-3F7C070F-2729-4DE1-9E1D-853E7F71934E

Q35027220-4168CA95-0A39-4215-B457-44879915C4CE

Q35027220-46713DCD-98E0-4665-A929-AA6F5037D4E5

Q35027220-597E411E-7B94-478D-AB4A-536ABF81026B

Q35027220-5A8E50B8-17F9-4C8B-AF6C-AB1B0BA73C68

Q35027220-64458E12-1BD7-4783-A5A6-030E1BD7CA62

P304

Q35027220-8824183B-6245-4841-9912-9C73B0B6B1A1

P31

Q35027220-3D50CDC2-589A-4866-B426-57612683AEBA

P356

Q35027220-B0025CC6-629D-4031-8A4C-DA0C61C41FBF

P433

Q35027220-988F5F00-D4C6-499E-BD83-60261EE50366

P478

Q35027220-67124210-E04B-47B4-8E02-4DBF1FD0F107

P50

Q35027220-0B675C28-F8C6-42B2-9B72-C86780109AA9

Q35027220-6FF7B3EF-0D86-4A98-927A-84FF65F87C86

Q35027220-EB734A38-602A-42AF-81E7-7E95BBEAB0B9

P577

Q35027220-FEB26A6D-DFF0-4091-99D6-CF74D96A31CD

P698

Q35027220-DB148FF0-FC9D-4F75-A36B-249236C6B9A1

P932

Q35027220-508E57C7-86BD-4583-B724-2C493B1A2FB2

P356

P1433

Journal of the American Society of Nephrology

P1476

HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients.

@en

P2093

Bernd Genser

http://www.w3.org/2001/XMLSchema#string

Christiane Drechsler

http://www.w3.org/2001/XMLSchema#string

Christoph Wanner

http://www.w3.org/2001/XMLSchema#string

Eberhard Ritz

http://www.w3.org/2001/XMLSchema#string

Günther Silbernagel

http://www.w3.org/2001/XMLSchema#string

Tatjana Stojakovic

http://www.w3.org/2001/XMLSchema#string

Vera Krane

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Lipid-related markers and cardiovascular disease prediction.

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.

The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis

Uremia alters HDL composition and function

P304

484-492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2013080816

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

Hubert Scharnagl

Tanja B Grammer

P577

2014-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25012163

http://www.w3.org/2001/XMLSchema#string

P932

4310646

http://www.w3.org/2001/XMLSchema#string